Bird flu is spreading. Could cow vaccines be the answer?

Also: Grindr hires Tom Daschle's firm to lobby on HIV prevention, IVF

July 29, 2024 Check out STAT+

Sponsored By

Illustration: Christine Kao/STAT; Photos: Adobe Could cow vaccines help halt the spread of bird flu in U.S. herds? Experts are divided Multiple animal vaccine manufacturers are researching a bird flu shot for cows, but many scientists question the timing and effectiveness of that approach. By Helen Branswell Blood tests for Alzheimer's diagnosis were 91% accurate in new study Blood tests were 91% accurate in diagnosing Alzheimer's in a Swedish study published in JAMA. But blood tests vary in quality. By Associated Press Dating app Grindr hires Tom Daschle's firm to lobby on HIV prevention, IVF Dating app hires Daschle Group, founded by former Senate Democratic leader Tom Daschle, to lobby on HIV prevention, surrogacy, and IVF. By Nicholas Florko and Sarah Owermohle Kristoffer Tripplaar/Sipa via AP STAT+ | Sarepta demanded Duchenne patient advocacy group censor video critical of the company The incident involving Parent Project Muscular Dystrophy raises questions about whether Sarepta seeks to muzzle debate over its Duchenne medicines. By Adam Feuerstein New cardiovascular risk model could greatly decrease use of statins and increase heart attacks, study warns As guidelines for prescribing statins and high blood pressure drugs are being reconsidered, new studies point to large potential harms. By Elizabeth Cooney Advancements in biomarker testing unlock precision oncology care For maximum effectiveness, each new cancer treatment must reach every patient who needs it, when they need it. But this can be difficult to achieve. To illustrate the challenges involved in matching treatments with patients in real time, Mia Levy, chief medical officer at Foundation Medicine, cited crizotinib, a kinase inhibitor that combats ALK- or ROS1-positive metastatic non-small cell lung cancer (NSCLC). Initially approved in 2011 to treat metastatic NSCLC, crizotinib is being developed for deployment across the full spectrum of NSCLC stages, including in a curative setting. By Sydney Klein Adobe STAT+ | In a big step for liquid biopsy, FDA approves a blood screening test for colorectal cancer Colon cancer is the second-most diagnosed cancer in the U.S. and the second-leading cause of cancer death. By Matthew Herper

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser